BioSpace News Archive

Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today cash and cash equivalents of €3.1 million as of September 30, 2019

The opening shortens the commute for residents of Upland and of most nearby cities who are seeking leading-edge oncology treatment

According to the Centers for Disease Control and Prevention (CDC), the flu virus can spread to others up to six feet away.

Three hospital associations in New Jersey, Ohio and Pennsylvania announced the creation of Q3 Health Innovation Partners, a new joint venture to improve health quality and patient safety.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the first patient has been enrolled in the REFINE-ALS clinical study, designed to identify and measure specific biomarkers and clinical assessments in up to 300 people with amyotrophic lateral sclerosis (ALS) in the United States who have begun treatment on RADICAVA® (edaravone).

Event recognizes individuals dedicated to empowering people affected by myeloproliferative neoplasms

Healthcare marketers now have a new privacy and HIPAA compliant way to create accurate customer segments and targeting models from Prosper’s new Model Factory on AWS SageMaker platform.

We at CEL-SCI have been believers in the value of immunotherapy for treating cancer for decades before others recognized it’s potential.

Cash balance anticipated to extend into 2021

- Episodes of hypothermia in preterm birth infants is high and there is potential for AmnioBed™ and artificial womb to be a game changer in the field of neonatology